Arkolith/Insider Trading/ZIVO/Form 4

Maggiore Christopher D.

Director, 10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Aug 23, 2024
Net Buying
Open-Market Buys
$261K
Open-Market Sells
$0
Net Open-Market Flow
$261K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2024Buy(P)31K$8.34$261K498K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2024Buy(P)3K$8.34$26K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-24-011071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML